- Millennium Hotel Paris CDG, France
October 17-19, 2025 - +1-571-5561014
pharmarnd@precisionglobalconferences.com
scientific Sessions
Bioavailability and Bioequivalence Studies
Bioavailability tests examine the absorption and concentration of the active ingredient in the body. This test is important for the rapid and efficient absorption, distribution, metabolism, and elimination of the drug. In contrast, the bioequivalence studies compare the bioavailability of a generic drug with its branded counterpart, ensuring that the generic version provides the same therapeutic efficacy and safety profile This study is critical to approving generics and ensuring patients receive flying treatments effective and consistent.
The Pharma R&D and Drug Discovery World Conference (PRDWC) provides an opportunity to discuss progress and challenges in bioavailability and bioequivalence studies. Seminars cover topics such as the effects of pharmaceutical formulations on drug absorption, regulatory requirements, and technologies, which improve the accuracy and efficiency of this research. Experts share insights to improve predictable and reliable bioequivalence and ensure safe and effective treatment choices for patients.
Related Sessions
Don't miss our future updates!